In the last trading session, 7.2 million shares of the Bicara Therapeutics Inc (NASDAQ:BCAX) were traded. Most recently the company’s share price was $9.27, and it changed around -$6.39 or -40.80% from the last close, which brings the market valuation of the company to $505.55M. BCAX currently trades at a discount to its 52-week high of $28.09, offering almost -203.02% off that amount. The share price’s 52-week low was $8.91, which indicates that the current value has risen by an impressive 3.88% since then.
Bicara Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.29. If we narrow it down even further, the data shows that 1 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended BCAX as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Bicara Therapeutics Inc is expected to report earnings per share of -0.55 for the current quarter.
Bicara Therapeutics Inc (NASDAQ:BCAX) trade information
Instantly BCAX has showed a red trend with a performance of -40.80% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 15.77 on recent trading dayincreased the stock’s daily price by 41.22%. The company’s shares are currently down -46.79% year-to-date, but still down -35.94% over the last five days. On the other hand, Bicara Therapeutics Inc (NASDAQ:BCAX) is -40.69% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $28, which translates to bulls needing to increase their stock price by 66.89% from its current value. Analyst projections state that BCAX is forecast to be at a low of $8 and a high of $48.
Forecasts for the next quarter put sales growth at 0.00%.
Bicara Therapeutics Inc earnings are expected to increase by 42.88% in 2025, but the outlook is positive 11.95% per year for the next five years.
BCAX Dividends
Bicara Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Select Portfolios-Health Care Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 700.0 shares worth $6.49 million, making up 1.28% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 636.55 shares worth around $5.9 million, which represents about 1.17% of the total shares outstanding.
